Healthcare Equipment and Supplies Stocks Post Mixed Q1 Results

Earnings

โดย StockStory·Read original

Summary · why it matters

Healthcare equipment and supplies stocks reported mixed first-quarter results, with the 37 companies tracked collectively beating revenue estimates by 2.3% but issuing next-quarter guidance 1.3% below expectations. Lantheus posted revenues of $377.3 million, up 1.2% year on year and exceeding estimates by 6.4%, though its full-year revenue guidance missed. STAAR Surgical delivered the strongest performance, with revenues surging 120% to $93.52 million and beating estimates by 20.8%, while Stryker was the weakest, reporting $6.02 billion in revenue that fell 5% short of expectations. Abbott Laboratories reported $11.16 billion in revenue, up 7.8% and beating estimates by 1.3%, and Integra LifeSciences posted $391.9 million, up 2.4% and exceeding estimates by 2.6%. On average, share prices across the group have declined 1.4% since the latest earnings results.

STAAR Surgical Company ▲

Lantheus Holdings Inc ±

Stryker Corporation ▼

Abbott Laboratories ▲

Integra LifeSciences Holdings ▲

Impact on stocks 5

Biotech & Genomic Medicine▲ · 3 stocks

Lantheus Holdings Inc

± MixedCapitalrelevance

Revenue beat estimates by 6.4% but full-year guidance missed.

Abbott Laboratories

▲ PositiveCapitalrelevance

Revenue beat estimates by 1.3% and grew 7.8% year on year.

Integra LifeSciences Holdings

▲ PositiveCapitalrelevance

Revenue exceeded estimates by 2.6% and grew 2.4% year on year.

Aging Population▲ · 1 stocks

STAAR Surgical Company

▲ PositiveCapitalrelevance

Revenue surged 120% and beat estimates by 20.8%, the strongest performance.

Robotics & Physical AI▼ · 1 stocks

Stryker Corporation

▼ NegativeCapitalrelevance

Revenue fell 5% short of expectations, the weakest in the group.